Type I gamma phosphatidylinositol phosphate 5-kinase i5 controls cell sensitivity to interferon
Developmental Cell · 2024
DOI: 10.1016/j.devcel.2024.02.005 ↗At a glance
Journal article in Developmental Cell, 2024. Written by Chinmoy Ghosh and 7 co-authors. Institution: Department of Oral and Craniofacial Molecular Biology, Philips Institute for Oral Health Research, School of Dentistry, Virginia Commonwealth Univers…. Major MEDLINE topics: Interferon-gamma, Phosphotransferases (Alcohol Group Acceptor), Signal Transduction. Cited 3 times so far (Crossref); 84 references. The full text is freely available in PubMed Central. Funded by: NCI NIH HHS, NIDCR NIH HHS, National Institutes of Health.
Abstract (original language)
The interferon signaling pathway is critical for host defense by serving diverse functions in both innate and adaptive immune responses. Here, we show that type I gamma phosphatidylinositol phosphate 5-kinase i5 (PIPKIγi5), an enzyme that synthesizes phosphatidylinositol-4,5-bisphosphate (PI4,5P2), controls the sensitivity to interferon in both human and mouse cells. PIPKIγi5 directly binds to the interferon-gamma (IFN-γ) downstream effector signal transducer and activator of transcription 1 (STAT1), which suppresses the STAT1 dimerization, IFN-γ-induced STAT1 nuclear translocation, and transcription of IFN-γ-responsive genes. Depletion of PIPKIγi5 significantly enhances IFN-γ signaling and strengthens an antiviral response. In addition, PIPKIγi5-synthesized PI4,5P2 can bind to STAT1 and promote the PIPKIγi5-STAT1 interaction. Similar to its interaction with STAT1, PIPKIγi5 is capable of interacting with other members of the STAT family, including STAT2 and STAT3, thereby suppressing the expression of genes mediated by these transcription factors. These findings identify the function of PIPKIγi5 in immune regulation.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Oral and Craniofacial Molecular Biology, Philips Institute for Oral Health Research, School of Dentistry, Virginia Commonwealth University, Richmond, VA 23298, USA.
- Department of Medicinal Chemistry, Institute for Structural Biology, Drug Discovery and Development, School of Pharmacy, Virginia Commonwealth University, Richmond, VA 23298, USA.
- Department of Human and Molecular Genetics, School of Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA.
- Department of Medicinal Chemistry, Institute for Structural Biology, Drug Discovery and Development, School of Pharmacy, Virginia Commonwealth University, Richmond, VA 23298, USA; Massey Cancer Center, Virginia Commonwe…
- Department of Human and Molecular Genetics, School of Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA; Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298, USA.
- Department of Oral and Craniofacial Molecular Biology, Philips Institute for Oral Health Research, School of Dentistry, Virginia Commonwealth University, Richmond, VA 23298, USA; Massey Cancer Center, Virginia Commonwea…
Funding
- NCI NIH HHS
- NIDCR NIH HHS
- National Institutes of Health
- NIDCR
Cite
APA
Ghosh, C., Kakar, R., Hoyle, R. G., Liu, Z., Guo, C., Li, J., Wang, X. Y., & Sun, Y. (2024). Type I gamma phosphatidylinositol phosphate 5-kinase i5 controls cell sensitivity to interferon. Developmental Cell. https://doi.org/10.1016/j.devcel.2024.02.005
Vancouver
Ghosh C, Kakar R, Hoyle RG, Liu Z, Guo C, Li J, et al. Type I gamma phosphatidylinositol phosphate 5-kinase i5 controls cell sensitivity to interferon. Developmental Cell. 2024. doi:10.1016/j.devcel.2024.02.005
BibTeX
@article{Ghosh2024,
author = {Ghosh, Chinmoy and Kakar, Ruchi and Hoyle, Rosalie G and Liu, Zheng and Guo, Chunqing and Li, Jiong and Wang, Xiang-Yang and Sun, Yue},
title = {Type I gamma phosphatidylinositol phosphate 5-kinase i5 controls cell sensitivity to interferon},
journal = {Developmental Cell},
year = {2024},
doi = {10.1016/j.devcel.2024.02.005}
}
EUVIMED